PMID- 20309529 OWN - NLM STAT- MEDLINE DCOM- 20101210 LR - 20211020 IS - 1432-2072 (Electronic) IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 210 IP - 1 DP - 2010 May TI - Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys. PG - 75-83 LID - 10.1007/s00213-010-1818-7 [doi] AB - RATIONALE: The effectiveness of MDMA and its enantiomers to reinstate responding previously maintained by drug self-administration has not been thoroughly investigated. OBJECTIVES: The present study was designed to compare the reinstatement effects of amphetamine, the piperazine-analog BZP, SR(+/-)-MDMA, S(+)-MDMA, R(-)-MDMA, and fenfluramine on behavior maintained under a second-order schedule of intravenous amphetamine self-administration in rhesus monkeys (n=4). METHODS: Following saline substitution and extinction, a range of doses of amphetamine, BZP, SR(+/-)-MDMA, S(+)-MDMA, R(-)-MDMA, and fenfluramine were administered i.v. as non-contingent priming injections in order to characterize their effectiveness to reinstate responding previously maintained by amphetamine self-administration. RESULTS: Priming injections of amphetamine, BZP, SR(+/-)-MDMA, and S(+)-MDMA induced significant reinstatement effects. In contrast, neither R(-)-MDMA nor fenfluramine effectively reinstated behavior. Pretreatment with the selective serotonin transporter inhibitor, fluoxetine, attenuated the reinstatement effects of SR(+/-)-MDMA, S(+)-MDMA, and BZP but had no significant effect on amphetamine-primed reinstatement. CONCLUSIONS: Given the profile of neurochemical effects published previously, these findings suggest that the reinstatement effects of MDMA are mediated primarily by dopamine release; however, the attenuation of MDMA-induced reinstatement by fluoxetine supports previous research demonstrating the complex behavioral pharmacology of MDMA-like drugs and that the reinstatement effects of MDMA are at least partially mediated by serotonergic mechanisms. FAU - McClung, Jessica AU - McClung J AD - Division of Neuroscience, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. FAU - Fantegrossi, William AU - Fantegrossi W FAU - Howell, Leonard L AU - Howell LL LA - eng GR - K02 DA000517/DA/NIDA NIH HHS/United States GR - K02 DA000517-10/DA/NIDA NIH HHS/United States GR - R37 DA010344/DA/NIDA NIH HHS/United States GR - R37 DA010344-13/DA/NIDA NIH HHS/United States PT - Comparative Study PT - Journal Article DEP - 20100323 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - CK833KGX7E (Amphetamine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Amphetamine/*administration & dosage MH - Animals MH - Dose-Response Relationship, Drug MH - Female MH - Macaca mulatta MH - N-Methyl-3,4-methylenedioxyamphetamine/*administration & dosage/*analogs & derivatives MH - Reaction Time/drug effects/physiology MH - *Reinforcement Schedule MH - Self Administration MH - Stereoisomerism PMC - PMC2862592 MID - NIHMS196550 EDAT- 2010/03/24 06:00 MHDA- 2010/12/14 06:00 PMCR- 2011/05/01 CRDT- 2010/03/24 06:00 PHST- 2009/10/29 00:00 [received] PHST- 2010/02/23 00:00 [accepted] PHST- 2010/03/24 06:00 [entrez] PHST- 2010/03/24 06:00 [pubmed] PHST- 2010/12/14 06:00 [medline] PHST- 2011/05/01 00:00 [pmc-release] AID - 10.1007/s00213-010-1818-7 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2010 May;210(1):75-83. doi: 10.1007/s00213-010-1818-7. Epub 2010 Mar 23.